retatrutide fat loss clinical trial results Before and After: Doctor Reveals Real Perceived benefits of treatment for

Both Zepbound and Retatrutide work by changing how your body responds to hunger and food

Months 6 to 12 and beyond: maximum results and maintenance The STEP trials showed that semaglutide 2.4 mg produces an average of approximately 15% body weight loss by week 68, roughly 16 months

Triple-action medications go one step further by targeting GIP, GLP-1, and glucagon receptors

(Source: KFF, January 2026) Even Where Covered, Utilization Controls Limit Access When state Medicaid programs do cover GLP-1s, coverage is typically subject to prior authorization and other utilization controls that further restrict access in practice

This means the appetite suppression does not continue to increase proportionally with dose beyond a certain point

Vaduganathan, M